Related by context. All words. (Click for frequent words.) 82 candidate Puricase 76 refractory gout 68 SinuNase ™ 68 personalized cellular immunotherapy 68 individualized cellular immunotherapy 67 vaginally administered lidocaine 67 Solazed TM 67 methylnaltrexone bromide 67 FOLOTYN ® 66 acetonide FA 66 Peyronie disease Frozen Shoulder 66 Disease IBD 66 molecular imaging radiopharmaceutical 66 lucinactant 66 novel histone deacetylase 66 ALN PCS 66 oral prodrug 66 topically applied SEPA 66 targeting Inflammatory Bowel 66 Zemiva TM 66 treat dysmenorrhea 66 CRMD# 66 investigational pharmacologically unique 66 sapropterin dihydrochloride 66 R Saizen R 65 include PLX IBD 65 Cleviprex TM clevidipine 65 Personalized Immunotherapy 65 SPL# Gel vaginal microbicide 65 MOVIPREP R 65 overactive bladder AA# 65 tiapamil 65 candidate MyVax 65 diarrhea predominant irritable 65 candidate epratuzumab 65 SinuNase TM 65 PDX pralatrexate 65 LibiGel ® 65 candidate XP# 64 reslizumab 64 Friedreich Ataxia FRDA 64 candidate Zemiva TM 64 vaccines oncolytic virus 64 candidate Zenvia 64 Zorbtive TM 64 Xcytrin R 64 markets HP Acthar 64 ELADUR TM 64 Frozen Shoulder syndrome Adhesive 64 Locteron ® 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 mGluR5 negative 64 rusalatide acetate 64 POSIDUR TM ELADUR TM 64 treat male hypogonadism 64 Panzem R 64 sodium thiosulfate STS 64 treat opioid induced 64 oncolytic virus therapies 64 FACTIVE R gemifloxacin 64 Aganocide 64 BEMA Granisetron 64 BiovaxID TM 64 candidates bavituximab 64 Luveris R Ovidrel R 64 FUSILEV ® 64 Prodarsan R 63 toenail onychomycosis 63 allosteric modulator NAM 63 HuMax HepC TM 63 Ovitrelle R Serostim 63 TRANSDUR ® 63 include Healive 63 mesylate tablets 63 BENLYSTA TM 63 acyclovir Lauriad R 63 vaginal candidiasis 63 oxypurinol 63 Auxilium transmucosal film 63 delivers fluocinolone acetonide FA 63 Archexin 63 Elagolix 63 Intravenous Human 63 dextofisopam 63 pralatrexate injection folate analogue 63 SUPPRELIN R LA 63 candidate Gencaro TM 63 product Fentanyl TAIFUN 63 SPRYCEL ® 63 syndrome overactive bladder 63 targeted radiotherapeutic 63 Entereg R 63 ALN HPN 63 vaginal lidocaine 63 including eniluracil ADH 63 REMOXY R 63 IV APAP 63 candidate deforolimus 63 KRYSTEXXA TM pegloticase 63 Zemiva ™ 63 Perflubutane Polymer Microspheres 63 MKC# MT 63 intranasal formulation 63 Crofelemer budesonide foam 63 AAG geldanamycin analog 63 Rhucin ® recombinant 63 VIVITROL ® 63 Onalta ™ 63 Opterone R 63 ELADUR ™ 63 TRANSDUR TM Sufentanil 63 delivery polymer matrix 63 lexidronam injection 63 bucindolol hydrochloride 63 arsenic trioxide injection 63 candidates Azedra TM 63 Injectable Suspension 62 TLK# 62 Surfaxin LS 62 TRANSDUR ™ 62 Initiate Clinical Trial 62 inflammatory autoimmune diseases 62 2 methoxyestradiol 62 Testosterone MDTS ® 62 opioid induced bowel dysfunction 62 HYVISC R 62 NicVAX TM 62 catheter occlusion 62 Spiegelmer ® 62 anti infective treatments 62 pan histone deacetylase 62 sapropterin dihydrochloride Tablets 62 sterile lidocaine patch 62 Phase IIb clinical trials 62 Lymphoseek ® 62 granulated mesalamine 62 non nucleoside inhibitor 62 Proquin XR 62 FDA APPROVES 62 Meets Primary Endpoint 62 ALVESCO ® 62 Vitrasert R 62 P#X# antagonist 62 virus HCV protease inhibitor 62 therapy Tovaxin 62 selective immunoproteasome inhibitor 62 Achieves Primary Endpoint 62 Iluvien ® 62 refractory chronic lymphocytic 62 Kuvan TM sapropterin 62 transthyretin mediated amyloidosis ATTR 62 Anturol ® 62 5 lipoxygenase inhibitor 62 Gel repository corticotropin injection 62 product platforms AZX# 62 dextromethorphan quinidine 62 apricitabine ATC 62 recombinant biopharmaceutical 62 R#/MEM # 62 candidates Azedra 62 Anturol TM 62 Submits NDA 62 BENLYSTA ™ 62 PF # [002] 62 orally inhaled migraine 62 novel L DOS# 62 aerosolized AAT 62 Biopharmaceuticals AG 62 NASH Huntington 62 faropenem medoxomil 62 investigational humanized monoclonal antibody 62 SILENOR 61 JZP 61 forodesine 61 Phase Ib clinical trials 61 Novel Oral 61 investigational antiplatelet agent 61 Staphylococcus aureus Immune Globulin 61 RANK Ligand inhibitor 61 Serostim ® 61 QNEXA ® 61 ® bortezomib 61 Therapeutic Competitors companiesandmarkets.com adEgemonye 61 topical non steroidal 61 Initiates Enrollment 61 non alcoholic steatohepatitis 61 LymphoStat B TM 61 alvespimycin 61 nalbuphine ER 61 R metformin Concor 61 candidate SILENOR TM 61 Cetrorelix 61 Phase 2b Trial 61 Amgen Neulasta R 61 OMNARIS HFA 61 StaphVAX R 61 GVAX ® 61 AzaSite Plus 61 TRANSDUR Bupivacaine 61 AERx ® 61 ZEVALIN ® 61 Bioaccelerate compounds under 61 Kuvan R 61 PNP inhibitor 61 Gonal f R 61 Unit Dose Budesonide 61 Parkinson disease levodopa induced 61 Begins Dosing 61 Veronate R 61 Vicriviroc 61 Completes Patient Enrollment 61 brand ciclesonide HFA 61 albiglutide 61 developing ostarine selective 61 Onalta 61 gastrointestinal mucositis 61 THR beta agonist 61 overactive bladder VANTAS 61 prokinetic agent 61 Vitrasert ® 61 LymphoStat B belimumab 61 Initiates Phase II 61 octreotide implant 61 INTEGRILIN R eptifibatide Injection 61 trastuzumab DM1 T DM1 61 Solazed ™ 61 Inhalation Solution 61 nasal decolonization 61 Zenvia ™ 61 Cardium Therapeutics TM 61 SYCREST 61 PRT# 61 candidate NGX 61 modified glutathione analog 61 Inhalation Aerosol 61 treat chronic sinusitis 61 nephropathic cystinosis cystinosis 60 Phase III Pivotal 60 Augment TM 60 oral taxane 60 TBC# 60 GVAX R 60 oxybutynin ATD TM 60 interferon beta 1a infertility 60 lomitapide 60 Fx #A 60 Albugon 60 ADL# novel 60 Azedra TM 60 Xyfid TM 60 Myocet 60 diarrhea fatigue asthenia 60 Phase IIb Trial 60 TRISENOX R 60 candidate brentuximab vedotin 60 Aerosurf 60 TOCOSOL 60 Fibrin Patch 60 Azedra TM Onalta TM 60 candidate Zemiva 60 dasatinib Sprycel ® 60 alvimopan 60 Solution XOPENEX HFA 60 Pivotal Phase III 60 somatropin Kuvan R 60 BrachySil TM 60 TELINTRA R 60 vapreotide acetate 60 Varespladib 60 Generx TM 60 R bendamustine hydrochloride 60 AzaSite Xtra 60 5 HT3 antagonist 60 Celacade TM technology 60 Kosan dependence 60 LE SN# 60 R bisoprolol Euthyrox 60 COLAZAL R 60 sodium Injection 60 cardiometabolic diseases Glucophage 60 itraconazole Sporanox 60 Phase 2a clinical 60 glucokinase activator 60 Mg Usa 60 include Phenoptin TM 60 transmucosal delivery system 60 anti CD3 monoclonal 60 GEM OS2 60 combines bupropion 60 serine protease inhibitor CU# 60 ularitide 60 ORE# 60 Neo Kidney Augment 60 patented Bioral 60 dihydrochloride Tablets 60 Veronate 60 R#/MEM 60 VISICOL R 60 Pegloticase 60 Clolar ® 60 Oasmia 60 Phase 2b Clinical Trial 60 RhuDex ® 60 Telik logo TELINTRA 60 generation DACH Platinum 60 candidates Augment ™ 60 ocular formulation 60 Receives Orphan Drug Designation 60 www.ucb group.com 60 EVIZON ™ 60 DIRECT Trial 60 Phase III Clinical Trial 60 Phase 2b clinical trials 60 pharmacokinetic PK study 60 vaginal lidocaine product 60 rheumatoid arthritis thrombocytopenia 60 Fortical R 60 TRO# 60 Omigard 60 Aryplase 60 Empatic ™ 60 Unigene nasal calcitonin 60 cromolyn sodium 60 cyclobenzaprine hydrochloride extended 60 IL# PE#QQR 60 candidate REP# 60 mertansine 60 elotuzumab 60 inhaled formulation 60 RECOTHROM R 60 ZADAXIN ® 60 Immunotherapeutic 60 oral beclomethasone dipropionate 60 Genasense ® oblimersen 60 platforms GVAX 60 cancer neuroendocrine tumor 60 Xeloda ® 60 Polyphenon ® E 60 commercializing therapeutic 60 highly purified pasteurized 60 R sipuleucel T 60 isoform selective 59 CCR9 antagonist 59 Civacir 59 leading oral taxane 59 XP# XP# 59 Phase III Trial 59 Aganocide ® 59 Nasdaq OPTR 59 Entereg TM 59 DPX Survivac 59 see CONTRAINDICATIONS WARNINGS 59 Fibrillex TM 59 TELINTRA 59 Wafer polifeprosan 59 DUROS 59 Liprotamase 59 overactive bladder VANTAS R 59 Luteinizing Hormone Releasing Hormone 59 antiangiogenesis therapies 59 inhibitor PPI 59 oral nucleoside analogue 59 Zemiva TM Trofex TM 59 IV Busulfex 59 Tezampanel 59 DURECT proprietary 59 MKC# MKC# PP 59 topical anti infective 59 cetuximab Erbitux R 59 PI3K/Akt pathway inhibitor 59 particularly SANCTURA XR 59 XL# anticancer compounds 59 EVIZON TM squalamine lactate 59 talactoferrin 59 carcinoma mCRC 59 miconazole Lauriad ® 59 opioid bowel dysfunction 59 dependent kinase inhibitor 59 R famotidine 59 antibody MAb 59 PARI Pharma 59 REMOXY ® 59 kidney urologic 59 * olmesartan medoxomil 59 Locteron combines 59 ALVESCO R 59 DIFICID ™ 59 generation purine nucleoside 59 expanded autologous cellular 59 Evoltra ® 59 Aurexis 59 PolyActive ® 59 Initiates Clinical 59 severe hypercholesterolemia 59 CTAP# Capsules 59 liposomal formulation 59 GLP1 INT TM 59 Demonstrates Positive 59 Pruvel TM 59 investigational pan BCR 59 vernakalant oral 59 CINQUIL 59 EnzymeRx 59 oritavancin semi 59 ospemifene 59 orally inhaled 59 biosurgical 59 bardoxolone 59 Solazed 59 lead molecular radiotherapeutic 59 GATTEX TM 59 NAGS deficiency 59 oral ghrelin agonist 59 candidate AQ4N 59 AERx R 59 Bazedoxifene 59 Navelbine ® 59 Microplasmin 59 ILUVIEN ® 59 hyperphenylalaninemia HPA due 59 MyVax ® 59 NEBIDO VANTAS SUPPRELIN LA 59 drug ISA# 59 Frozen Shoulder Syndrome 59 Exelixis compounds 59 metaglidasen 59 Phase IIb trials 59 prescribed proton pump 59 Androxal TM 59 CORLUX CORT # 59 Exherin TM 59 zileuton tablets 59 KNS # 59 Lixivaptan 59 nasal calcitonin product 59 mitogen activated ERK kinase 59 tizanidine hydrochloride short 59 Symphony tCGM 59 ATL/TV# 59 torsemide ER 59 Itopride 59 external counterpulsation systems 59 Nanobody R 59 Sulonex TM 59 Cerebril TM 59 thetreatment 59 Elestrin ® 59 POSIDUR ™ 59 MIVI III 59 ONSOLIS TM 59 Phase IIb Clinical Trial 59 pigmentary disorders 59 Anturol 59 novel therapeutic antibodies 59 rALLy clinical trial 59 Cytogen marketed 59 INSPIRE Trial Phase III 59 mocetinostat MGCD# 59 Phase #b/#a clinical 59 ITAX 59 MEK inhibitor RDEA# 59 mecarbil 59 LEP ETU 59 beta 1a 59 CD# CEA 59 Files IND 59 zanolimumab 59 delivers sumatriptan 59 R brand levalbuterol 58 oxymorphone ER 58 phase III isavuconazole 58 PANVAC VF 58 omacetaxine mepesuccinate 58 Acetavance TM intravenous acetaminophen 58 R memantine HCl 58 SUMAVEL 58 Nasdaq IDIX biopharmaceutical 58 telomerase therapeutic 58 developing ACAPODENE 58 compound KOS 58 LEVADEX TM 58 NASDAQ CLSN 58 Azedra ™ 58 REPRONEX ® menotropins 58 Oracea TM 58 Celacade TM 58 cutaneous T 58 Pyridorin 58 corticotropin injection 58 JAK inhibitor 58 dihydrochloride 58 NEBIDO R 58 pseudobulbar affect PBA 58 novel antifolate currently 58 Cinryze ™ 58 AFREZZA TM 58 vinorelbine tartrate 58 memantine HCl 58 Trofex ™ 58 Captisol enabled 58 IMiDs R 58 Nicotine Conjugate Vaccine 58 candidate ATHX 58 ® lenalidomide 58 compound perifosine 58 Phase 2b study 58 signal detection CTSD 58 IMPDH inhibitor 58 XL# XL# 58 sapropterin dihydrochloride Phase 58 ELADUR 58 rxRNA 58 Phase 2a clinical trials 58 Troxatyl 58 KL4 Surfactant 58 Aflibercept 58 platinum chemotherapeutic 58 PDE4 inhibitor 58 postoperative ileus POI 58 huC# DM4 58 cardiac myosin activator omecamtiv 58 Locteron exclusively 58 QNEXA 58 leukotriene pathway 58 RECOTHROM ® 58 novel proprietary KL4 58 By JENNIFER LEARN 58 Initiate Phase 58 acute onset CINV 58 GW# [003] 58 novel orally inhaled 58 Genasense R oblimersen 58 multicenter Phase II 58 hormone LHRH antagonist 58 AERx iDMS 58 Luramist 58 Therapeutic Competitors Companies 58 ACAPODENE 58 Ceplene TM 58 recurrent herpes labialis 58 Ozarelix 58 Bosutinib 58 candidate TNFerade biologic 58 severe hypersensitivity reactions 58 histamine dihydrochloride 58 psoriasis rheumatoid arthritis 58 Cloretazine ® 58 Combination REOLYSIN R 58 Phase 2a trial 58 Recombinant Human 58 oral ridaforolimus 58 UltiMAb R technology 58 sulodexide 58 R roscovitine CDK cyclin 58 Ceflatonin R 58 oral picoplatin 58 HDL Mimetic Peptide 58 EVIZON TM 58 treat refractory angina 58 PHX# 58 intravenous ghrelin agonist 58 polysaccharide polymer 58 Neutrolin ® 58 EXPAREL TM 58 Sulonex 58 Ambrisentan 58 RenaZorb TM 58 ALTROPANE R 58 Proellex TM 58 Trofex TM 58 Kamada AAT 58 Benazepril 58 metastatic malignant 58 Aloxi R 58 Copegus ® 58 ACTEMRA TM 58 TRISENOX ® 58 Chrysalin r rusalatide acetate 58 oral proteasome inhibitor 58 Besivance 58 Dual Opioid 58 HCl PEPCID ® famotidine 58 nucleotide analog 58 opioid induced constipation 58 PRTX 58 Safinamide 58 Diabetic Macular Edema DME 58 hypoxia activated prodrug 58 INOmax R 58 MCSP respectively 58 candidate iSONEP TM 58 DG# compounds targeting 58 Drug Eluting Stent System 58 acne impetigo 58 proprietary intravenous formulation 58 cosmetic cosmeceutical products 58 Octreotide 58 oral methylnaltrexone 58 Rezular 58 omecamtiv mecarbil formerly 58 biased ligand 58 PEGylated anti 58 Gentamicin Surgical Implant 58 occlusion PAO 58 Allovectin 7 r 58 BARACLUDE R 58 disease CDAD 58 octreotide acetate 58 Fludara ® 58 BRILINTA 58 ketoprofen patch 58 ALN TTR# 58 R MSCRAMM 58 Amigal TM 58 Pirfenidone 58 Curaxin CBLC# 58 IMA# 58 Randomized Double blind 58 herpetic keratitis 58 KRYSTEXXA TM 58 INS# [001] 58 cobiprostone 58 delayed onset CINV 58 Factor VIIa 58 Phase III clinical 58 CDP# 58 candidate Liposomal Grb 58 phase Ib clinical 58 therapeutic peptide 58 Quinamed 58 investigational hepatitis C 58 Serdaxin ® 58 CYT# potent vascular disrupting 58 polymerase inhibitor 58 midstage clinical 58 Insegia 58 ACAPODENE TM 58 palonosetron hydrochloride injection 58 Simulect 58 Dual Opioid TM 58 Fentanyl Taifun 58 LEVADEX ™ 58 CINTREDEKIN BESUDOTOX 58 DPP4 inhibitor 58 FACTIVE ® 58 hyaluronidase enzyme 58 EXPAREL ™ 58 phenylalanine ammonia lyase 58 inhalation aerosol 58 OTCBB PYTO 58 MKC# 58 Oral NKTR 58 registrational trial 57 NuMimetic TM 57 ZANAFLEX CAPSULES ® tizanidine 57 telomerase inhibitor drug 57 renal dysfunction acute renal 57 R lenalidomide 57 selective androgen receptor modulator 57 Protexia ® 57 orBec ® oral beclomethasone 57 Angiocept 57 sodium glucose transporter 57 aldehyde dehydrogenase ALDH2 deficiency 57 Bepreve TM 57 Bioral ® 57 IMiDs ® 57 Calcium Acetate 57 midstage trials 57 TKM ApoB 57 oral isotype selective HDAC 57 velafermin 57 PEG PAL PEGylated recombinant 57 Coadministration 57 evaluating bafetinib 57 ORENCIA R 57 non nucleoside HCV 57 Pivotal Phase 57 Annamycin 57 delta gamma agonist 57 BCG refractory carcinoma 57 PhotoPoint R 57 HQK 57 dyskinesia PD LID 57 Nexavar sorafenib 57 CIP TRAMADOL ER 57 PREOS R 57 romazarit 57 containing granisetron 57 CCX# B 57 ENABLE Phase 2 57 MAGE A3 ASCI 57 Captisol ® 57 Pafuramidine 57 pioglitazone hydrochloride 57 pafuramidine maleate 57 injectable collagenase 57 Omigard TM 57 ulimorelin 57 armodafinil Tablets C 57 systemic RNAi 57 anti botulism antibody 57 lintuzumab SGN 57 Known hypersensitivity 57 investigational HCV polymerase 57 personalized immunotherapy 57 gastro intestinal inflammation 57 pioglitazone HCl 57 pan HDAC inhibitor 57 cathepsin K inhibitor 57 Genaera Corporation 57 post herpetic neuralgia PHN 57 % uracil topical 57 Phase 1b clinical trials 57 commercialize ZYFLO CR 57 intravenous AAT 57 Empatic TM 57 SUTENT ® 57 Oral Calcitonin 57 candidate CRLX# 57 milnacipran HCl 57 evaluating picoplatin 57 Panzem R NCD 57 muscarinic receptor agonist 57 orBec R oral beclomethasone 57 Azedra 57 MYDICAR ® 57 Ereska 57 Marqibo TM 57 CYP#A# CYP#D# 57 TFChem licenses 57 Copegus R 57 systemic fungal infections 57 edifoligide E2F Decoy 57 enoximone capsules 57 DURIN TM 57 Ophena TM 57 adalimumab Humira 57 Successfully Completes Phase 57 Firazyr 57 ABL inhibitor 57 intravascular hemolysis 57 Hedgehog Pathway Inhibitor 57 Pivotal Trial 57 ® pioglitazone HCl 57 Ceflatonin ® 57 PROSTASCINT R 57 Thelin tm 57 phase IIb trial 57 adrenergic regulation 57 phase IIb clinical 57 XL# XL# XL# XL# 57 Zingo TM 57 Nasdaq PGNX today 57 TOCOSOL Camptothecin 57 motexafin gadolinium Injection 57 budesonide foam 57 Somatuline R Autogel R 57 either acutely decompensated 57 erlotinib Tarceva R 57 Bioral Amphotericin B 57 docetaxel Taxotere R 57 novel VDA molecule 57 topical gel formulation 57 Cintredekin Besudotox 57 2 inhibitor CYT# 57 gastrointestinal disorders ATI 57 cell lymphoma CTCL 57 doxercalciferol 57 Phase IIb clinical 57 candidate ridaforolimus 57 Submits Response 57 multicenter Phase III 57 CAPHOSOL R 57 sorafenib tablets 57 NYSE Amex PTN 57 ATL# [002] 57 PEG PAL 57 HCV protease inhibitor 57 HuMax TAC 57 Commences Phase 57 BUPHENYL 57 PROVENGE ® 57 Phase IIa trial 57 AcryMed Incorporated 57 Alocrest 57 TNF Tumor Necrosis Factor 57 RELOVAIR ™ 57 initiate Phase 2b 57 PEGylated Fab fragment 57 apoptosis inducer 57 acute mania 57 GSK# [002] 57 Atripla combines 57 Ixempra 57 Hematide ™ peginesatide 57 ZEGERID Capsules 57 Medoxomil 57 TRAIL receptor antibodies 57 Pimavanserin 57 successfully commercialize Iluvien 57 ISENTRESS raltegravir 57 prostone 57 ATRA IV 57 includes TOLAMBA TM 57 Clonicel 57 non porcine pancreatic 57 rheumatoid arthritis osteoarthritis ankylosing 57 Alseres Cethrin 57 Neo Kidney Augment ™ 57 polymer platinate 57 cardio renal 57 CB2 selective receptor agonist 57 JUVISTA R Human 57 Inc Therapeutic Competitors 57 EOquin TM 57 Saforis 57 NUVIGIL ® 57 Cellegesic 57 REGN# 57 MetroGel 57 ATL# [001] 57 Acetavance TM 57 ALN TTR 57 Phase IIIb 57 NASDAQ CXSP announced 57 proprietary HuCNS SC 57 immunotherapeutic vaccine 57 Aztreonam lysine 57 Hematide TM 57 adenosine injection 57 candidate EFAPROXYN TM 57 Intravitreal 57 diagnostic radiopharmaceutical 57 signal averaging electrocardiography 56 Phase 2b clinical 56 phenylketonuria PKU developed 56 sapacitabine CYC# 56 Proxinium 56 Daclizumab 56 myocardial infarction ventricular fibrillation 56 Files Investigational 56 Loramyc TM 56 Phase III Clinical Trials 56 oral RSD# 56 Kyowa Kirin 56 Phase Ib II 56 relapsed multiple myeloma 56 STEDESA 56 R vancomycin hydrochloride 56 ORENCIA ® 56 oral dihydropyrimidine dehydrogenase DPD 56 ZOLINZA 56 PhosLo R 56 Phase 2a Clinical Trial 56 Solzira ™ 56 Pazopanib 56 HGS ETR1 mapatumumab 56 Vicinium TM 56 NeuroSTAT ® 56 Auxilium anticipates 56 QLT# 56 Vidaza R 56 OTCBB ARGA specialty 56 Presents Preclinical 56 SEPET TM 56 Tarvacin Anti Cancer 56 Aclidinium 56 HFA MDI 56 tafamidis 56 #L Sterilizer 56 initiated Phase Ib 56 Matrix Phase 2b 56 dexanabinol 56 novel immunotherapies 56 Agonist MABA program 56 Resten NG 56 phase IIb 56 Ketotransdel 56 ATPace TM 56 R sorafenib tablets 56 MAA submission 56 oral dual endothelin 56 GALNS 56 Harbor BioSciences 56 constipation OIC 56 transthyretin TTR mediated amyloidosis 56 adecatumumab MT# 56 Hedgehog antagonist 56 OTCBB QTXB 56 incyclinide 56 evaluating tivozanib 56 GLP toxicology studies 56 ionotropic glutamate receptor antagonists 56 urocortin 2 56 OTCBB HXBM developer 56 Bezielle 56 IMiD 56 Silodosin 56 novel DACH platinum 56 SNT MC# 56 TPI ASM8 56 Tesetaxel 56 androgen receptor modulator 56 phase IIa clinical 56 CIMZIA ™ 56 OMNARIS 56 phase IIa 56 commercializing anti infective 56 vitreoretinal disorders 56 intravenous acetaminophen 56 Dupuytren Disease 56 Dementia Related Psychosis 56 pentadentate logo R 56 Atrigel 56 tumor lysis syndrome 56 OHR/AVR# 56 IIb clinical trial 56 negative allosteric modulator 56 non peptidic protease 56 RNA interference RNAi therapeutics 56 Emezine 56 irinotecan containing 56 next generation URAT1 56 GED aPC 56 XL# XL# XL# 56 Eluting Coronary Stent System 56 inhibit oxidative stress 56 Initiates Phase III 56 Onconase 56 acetylgalactosamine 6 56 please visit http:/www.vandapharma.com 56 generation URAT1 inhibitor 56 Sular formulation 56 molecular imaging radiopharmaceuticals 56 Allovectin 7 56 Collategene 56 Loceryl ® 56 Generx ™ 56 dutogliptin 56 carcinoid syndrome 56 Tyzeka Sebivo 56 Pivotal Study 56 TKB# 56 RELISTOR ® 56 Albuferon albinterferon alfa 2b 56 Rhucin R 56 metformin accumulation 56 Afatinib 56 miconazole Lauriad R 56 Alexza Staccato 56 KALBITOR ® 56 Mipomersen 56 Cimzia TM 56 invasive candidiasis 56 phase 2a 56 albinterferon alfa 2b 56 brivaracetam 56 polyneuropathy HIV DSP 56 receptor tyrosine kinase inhibitor 56 IRX 2 56 Ferring Pharmaceuticals specializes 56 Aplidin 56 Iloperidone 56 Cutanea 56 granted Ortec 56 NYSE Amex PBTH 56 histone deacetylase HDAC inhibitor 56 Perforomist ™ Inhalation Solution 56 pneumococcal conjugated vaccine 56 dasatinib Sprycel 56 ELACYT 56 bevacizumab Avastin R 56 intranasal insulin product 56 NP2 Enkephalin 56 phase Ib 56 research anddevelopment 56 Proxinium TM 56 diabetic neuropathic pain 56 PORxin TM platforms 56 Soliris TM eculizumab 56 Cutanea Life Sciences 56 Sudhir Agrawal D.Phil 56 Epratuzumab 56 HEPLISAV ™ 56 AQ4N 56 Aganocide R 56 Tocosol Paclitaxel 56 Bioral Amphotericin B. 56 transmucosal delivery 56 Polymer Microspheres 56 glucocorticoid induced osteoporosis 56 exocrine pancreatic insufficiency 56 HIV distal sensory 56 dual endothelin receptor antagonist 56 anti amnesic 56 ozarelix 56 Duromist ™ 56 Circ Pharma